Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
The identification and functional evaluation of novel cancer-associated fibroblast subtypes and matrisome proteins in pancreatic cancer
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper.
2023 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)Alternativ titel
Identifiering och funktionell utvärdering av nya cancer-associerade fibroblast-subtyper och matrisomeproteiner i pankreascancer (Svenska)
Abstract [en]

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy characterized by an extensive desmoplastic stroma. The stroma is the site of intricate communication between malignant cells and their surrounding environment. This tissue microenvironment (TME) is populated by a heterogenous mixture of cell types and extracellular matrix proteins. Distinct stromal elements confer tumour-restraining or tumour-promoting influences on tumorigenesis. Characterizing stromal composition therefore represents an opportunity to identify candidates for therapeutic intervention to facilitate improved clinical outcomes. In this thesis we identify galectin-4 as an extracellular matrix protein which is upregulated in PDAC. We find that galectin-4 exerts a pro-tumorigenic influence in PDAC through promoting immune suppression, highlighting its potential as a novel therapeutic target. We subsequently provide a comprehensive characterization of mesenchymal cell diversity in PDAC including cancer-associated fibroblasts (CAFs) which represent one of the dominant stromal cellular components. We identify inflammatory CAF (iCAF) and myofibroblastic CAF (myCAF) subtypes in addition to defining a novel interferon-response CAF (ifCAF) subtype. In addition, we demonstrate that pancreatic stellate cells (PSCs) are capable of forming iCAFs, myCAFs and ifCAFs in response to tumour-derived signals using an organoid-based co-culture model and define biological pathways regulating CAF subtype formation. We then perform a high-throughput drug-screen using this co-culture model to identify compounds which can suppress tumour growth indirectly through modifying CAFs. One such compound is GNF-5 which we show can suppress cancer cell proliferation indirectly through manipulating CAF phenotype. Taken together, this thesis augments our understanding of the composition of the PDAC stroma and identifies potential therapeutic targets as well as developing an approach to discover drugs which yield a therapeutic benefit through targeting the PDAC stroma.   

Ort, förlag, år, upplaga, sidor
Umeå: Umeå University , 2023. , s. 122
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2259
Nyckelord [en]
Cancer-associated fibroblast (CAF), Single-cell RNA sequencing (scRNAseq), Pancreatic ductal adenocarcinoma (PDAC), Tumor microenvironment (TME), Extracellular matrix (ECM), Organoid-based co-culture model, Drug-screen
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
onkologi
Identifikatorer
URN: urn:nbn:se:umu:diva-215330ISBN: 9789180701747 (tryckt)ISBN: 9789180701754 (digital)OAI: oai:DiVA.org:umu-215330DiVA, id: diva2:1805713
Disputation
2023-11-17, Betula, 6M, Norrlands universitetssjukhus, Umeå, 13:00 (Engelska)
Opponent
Handledare
Tillgänglig från: 2023-10-26 Skapad: 2023-10-18 Senast uppdaterad: 2023-10-19Bibliografiskt granskad
Delarbeten
1. Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer
Öppna denna publikation i ny flik eller fönster >>Extracellular galectin 4 drives immune evasion and promotes T-cell apoptosis in pancreatic cancer
Visa övriga...
2023 (Engelska)Ingår i: Cancer immunology research, ISSN 2326-6066, Vol. 11, nr 1, s. 72-92Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Pancreatic ductal adenocarcinoma (PDAC) is characterized by rich deposits of extracellular matrix (ECM), affecting the pathophysiology of the disease. Here, we identified galectin 4 (gal 4) as a cancer cell produced protein deposited into the ECM of PDAC tumors and detected high circulating levels of gal 4 in PDAC patients. In orthotopic transplantation experiments we observed increased infiltration of T-cells and prolonged survival in immunocompetent mice transplanted with cancer cells with reduced expression of gal 4. Increased survival was not observed in immunodeficient RAG1-/- mice, demonstrating that the effect was mediated by the adaptive immune system. Furthermore, by performing single-cell RNA-sequencing we found that the myeloid compartment and cancer-associated fibroblast (CAF) subtypes were altered in the transplanted tumors. Reduced gal 4 expression was associated with higher proportion of myofibroblastic CAFs and reduced numbers of inflammatory CAFs. We also found higher proportions of M1 macrophages, T-cells and antigen presenting dendritic cells in tumors with reduced gal 4 expression. Using a co-culture system, we observed that extracellular gal 4 induced apoptosis in T-cells by binding N-glycosylation residues on CD3 epsilon/delta. Hence, we show that gal 4 is involved in immune evasion and identify gal 4 as a promising drug target for overcoming immunosuppression in PDAC. 

Ort, förlag, år, upplaga, sidor
American Association for Cancer Research, 2023
Nyckelord
Galectin 4, pancreatic cancer, immunosuppression, extracellular matrix, drug target
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
immunologi; medicin; onkologi
Identifikatorer
urn:nbn:se:umu:diva-201042 (URN)10.1158/2326-6066.CIR-21-1088 (DOI)36478037 (PubMedID)2-s2.0-85145492684 (Scopus ID)
Forskningsfinansiär
Stiftelsen för internationalisering av högre utbildning och forskning (STINT), PT2015-6432Cancerfonden, AMP17-877, LP18-2202, LP20-2257, LP 21-2298Vetenskapsrådet, 2017-01531Kempestiftelserna, JCK-1301, SMK-1765Svenska läkaresällskapet, SLS-890521, SLS-786661, SLS-691681, SLS-591551Västerbottens läns landsting, RV-930167, VLL-643451, VLL-832001SjöbergstiftelsenKnut och Alice Wallenbergs StiftelseMarianne och Marcus Wallenbergs Stiftelse, MMW 2020.0189Cancerfonden, CAN 2017/332, CAN 2017/827, 20 1339 PjFCancerfonden, AMP-18-919Knut och Alice Wallenbergs Stiftelse
Anmärkning

Originally included in thesis in manuscript form. 

Tillgänglig från: 2022-11-16 Skapad: 2022-11-16 Senast uppdaterad: 2023-10-18Bibliografiskt granskad
2. Dissecting FAP+ mesenchymal cell diversity and regulation uncovers an interferonresponse cancer-associated fibroblast subtype
Öppna denna publikation i ny flik eller fönster >>Dissecting FAP+ mesenchymal cell diversity and regulation uncovers an interferonresponse cancer-associated fibroblast subtype
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
urn:nbn:se:umu:diva-215328 (URN)
Tillgänglig från: 2023-10-18 Skapad: 2023-10-18 Senast uppdaterad: 2023-10-18
3. Potentiating the tumor-restraining properties of the stroma in pancreatic cancer with small molecules
Öppna denna publikation i ny flik eller fönster >>Potentiating the tumor-restraining properties of the stroma in pancreatic cancer with small molecules
Visa övriga...
(Engelska)Manuskript (preprint) (Övrigt vetenskapligt)
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
urn:nbn:se:umu:diva-215329 (URN)
Tillgänglig från: 2023-10-18 Skapad: 2023-10-18 Senast uppdaterad: 2023-10-18

Open Access i DiVA

fulltext(2470 kB)333 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 2470 kBChecksumma SHA-512
6978de2924655a5749afb06ea41955c73bdbef6a3ad3a057744e340ef965a70c85984badf4774e4172a8f5de40e19c46d084b447c174f7fc72ac37711e6d02d4
Typ fulltextMimetyp application/pdf
spikblad(123 kB)31 nedladdningar
Filinformation
Filnamn SPIKBLAD01.pdfFilstorlek 123 kBChecksumma SHA-512
65174d2a8e2e4983d826e9f14b40fe091269e0bb183bfeaf4deb38aa04406088f1d85dde615d176367ac5032fa1f64680681bbaf796e19e8f58bf00cdb22b98b
Typ spikbladMimetyp application/pdf

Person

Cumming, Joshua

Sök vidare i DiVA

Av författaren/redaktören
Cumming, Joshua
Av organisationen
Institutionen för strålningsvetenskaper
Cancer och onkologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 333 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

isbn
urn-nbn

Altmetricpoäng

isbn
urn-nbn
Totalt: 935 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf